Science

Jan 14, 2025, 12:19

5 papers about Lung Cancer suggested by Stephen Liu

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

1. Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Authors: Mehmet Altan et al.

2. Fam-Trastuzumab-Deruxtecan and Osimertinib Combination to Target HER2 Driven Resistance in a NSCLC Patient Following Osimertinib Progression: Case Report

Authors: Hailey M. Hirata et al.

5 papers about Lung Cancer suggested by Stephen Liu

3. Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer

Authors: Mehrdad Rakaee et al.

5 papers about Lung Cancer suggested by Stephen Liu

4. Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial

Authors: Yanjun Xu et al.

5 papers about Lung Cancer suggested by Stephen Liu

5. Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

Authors: Jacob Sands et al.

5 papers about Lung Cancer suggested by Stephen Liu

Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.

His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

cancer Georgetown University Hailey M. Hirata Jacob Sands Lung cancer Mehmet Altan Mehrdad Rakaee NSCLC OncoDaily Oncology osimertinib SCLC Stephen Liu Yanjun Xu

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage